DUBLIN--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/b92f8c/competing_in_the_u) has
announced the addition of Frost & Sullivan's new report "Competing in the U.S.
Contract Research Market" to their offering.
This study encompasses vital feedback provided by outsourcing decision makers
within pharmaceutical and biotechnology companies allowing contract research
organizations (CROs) to gain insight into current and future outsourcing
patterns and trends. Through the analysis provided, CROs will better be able to
understand motives and perceived benefits of outsourcing, criteria for CRO
selection and current and future technology requirements. Additionally,
competitive factors across CROs are analyzed with a special focus on the
nation's leading CROs. An analysis of clinical trial trends and patterns across
regions will allow CROs to understand where future growth opportunities may lie.
CROs will be able to use this valuable data to better understand how decisions
are made by their pharmaceutical and biotechnology customers, thereby allowing
them to further penetrate this dynamic and lucrative market.
There is some indication of a trend towards significant reductions in CRO
budgets in the next 12 to 24 months for the majority of institutions surveyed.
The source of this reduction appears to be an overall expectation of decline in
outsourcing costs, most likely due to intensifying competition, rather from a
decline in the rate of outsourcing itself. This implies that CROs need to have a
firmer grasp of what the market really wants, and how they evaluate CROs, to
stay competitive in a scenario of tightening CRO budgets.
Oncology and Cardiovascular research will continue to be areas with higher
levels of outsourcing, with some slight increase expected for Oncology research.
A slight increase is also expected in the area of Metabolic Diseases. There are
also indications of a possible slight decrease in the percentage of clinical
development outsourced in the area of Allergy / Respiratory Diseases. Other
potential trends and shifts across various areas of research and the various
phases are evaluated in the study.
The market can be segmented into 3 types of clients, based on their research
priorities and criteria for selecting CROs. The Full Service user is the largest
segment (47 percent), though relatively more selective in both its scope and
intensity of outsourcing, it has more sophisticated requirements, and seeks
technology services and data scalability. Heavy users (13 percent) have the
highest intensity of outsourcing and pursue a broad spectrum of research areas.
Price and Productivity Users (40 percent) consider price and the speed of
project turnaround as important. The study discusses each of these segments'
motives, priority areas and phases, and criteria for CRO selection. This implies
that CROs should know how to emphasize key capabilities that match each
particular segment's key criteria and research agenda to optimize its marketing
and sales effectiveness.
There is some indication of a possible slight shift in clinical trial activities
from North America to other regions. North America share of clinical trials is
expected to decrease from 61 percent to 53 percent in the next 3-5 years. The
regions that will benefit from this shift are discussed in the study.
Key Topics Covered:
1. Competing in the U.S. Contract Research Market
1.1 Executive Summary
1.2 Objectives and Methodology
1.3 Outsourcing Patterns and Trends
1.4 Motives and Perceived Benefits of Outsourcing
1.5 CRO Utilization, Satisfaction, and Preferences
1.6 Market Segments and Criteria for CRO Selection
1.7 CRO Performance Metrics
1.8 CROs Associated with Attributes
1.9 An Evaluation of 11 Large CROs
1.10 Patterns and Trends of Clinical Trials Across Regions
1.11 Other Technology Requirements: Current and Future
1.12 Purchase Behavior and Trends
For more information visit
http://www.researchandmarkets.com/research/b92f8c/competing_in_the_u
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Copyright Business Wire 2009
